Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Laya Ekhlaspour"'
Autor:
Laya Ekhlaspour, Bruce Buckingham, Colleen Bauza, Mark Clements, Gregory P. Forlenza, Anna Neyman, Lisa Norlander, Marcus Schamberger, Jennifer L. Sherr, Ryan Bailey, Roy W. Beck, Craig Kollman, Shannon Beasley, Erin Cobry, Linda A. DiMeglio, Emily Paprocki, Michelle Van Name, Antoinette Moran
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 36, Iss , Pp 100352- (2024)
Objectives: To report the safety and side effects associated with taking verapamil for beta-cell preservation in children with newly-diagnosed T1D. Research Design and Methods: Eighty-eight participants aged 8.5 to 17.9 years weighing ≥ 30 kg were
Externí odkaz:
https://doaj.org/article/4b4c5a73335044ad8e459e24a8c98975
Autor:
Roque Cardona-Hernandez, Klemen Dôvc, Torben Biester, Laya Ekhlaspour, Maddalena Macedoni, Martin Tauschmann, Chiara Mameli
Publikováno v:
Pharmacological Research, Vol 202, Iss , Pp 107109- (2024)
Externí odkaz:
https://doaj.org/article/f881b15de616401ea26cb1247fef1175
Autor:
Roque Cardona-Hernandez, Klemen Dôvc, Torben Biester, Laya Ekhlaspour, Maddalena Macedoni, Martin Tauschmann, Chiara Mameli
Publikováno v:
Pharmacological Research, Vol 195, Iss , Pp 106882- (2023)
Type 1 diabetes (T1D) is the most frequent form of diabetes in pediatric age, affecting more than 1.5 million people younger than age 20 years worldwide. Early and intensive control of diabetes provides continued protection against both microvascular
Externí odkaz:
https://doaj.org/article/5308bc8c0fc64f96beda5b97b60f091a
Autor:
R. Paul Wadwa, Zachariah W. Reed, Bruce A. Buckingham, Mark D. DeBoer, Laya Ekhlaspour, Gregory P. Forlenza, Melissa Schoelwer, John Lum, Craig Kollman, Roy W. Beck, Marc D. Breton
Publikováno v:
New England Journal of Medicine. 388:991-1001
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c580fe2e1f1100b47edca9928875ac4
https://doi.org/10.1056/nejmoa2210834
https://doi.org/10.1056/nejmoa2210834
Autor:
Jordan E, Pinsker, Eyal, Dassau, Sunil, Deshpande, Dan, Raghinaru, Bruce A, Buckingham, Yogish C, Kudva, Lori M, Laffel, Carol J, Levy, Mei Mei, Church, Hannah, Desrochers, Laya, Ekhlaspour, Ravinder Jeet, Kaur, Camilla, Levister, Dawei, Shi, John W, Lum, Craig, Kollman, Francis J, Doyle, Thomas, Eggerman
Publikováno v:
Diabetes technologytherapeutics. 24(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e46466133c1a20bfff9a30d79c4e1127
https://pubmed.ncbi.nlm.nih.gov/35549708
https://pubmed.ncbi.nlm.nih.gov/35549708
Autor:
Laya, Ekhlaspour, Marissa, Town, Dan, Raghinaru, John W, Lum, Sue A, Brown, Bruce A, Buckingham
Publikováno v:
Diabetes technologytherapeutics. 24(8)
Using a closed-loop system significantly improves time in range (TIR) 70-180 mg/dL in patients with type 1 diabetes (T1D). In a 6-month RCT, 112 subjects were randomly assigned to closed-loop control (Tandem Control-IQ) after obtaining 2 weeks of bas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22fb53effc36695521512a6a570b0718
https://pubmed.ncbi.nlm.nih.gov/35020488
https://pubmed.ncbi.nlm.nih.gov/35020488
Autor:
Gregory P. Forlenza, Laya Ekhlaspour, Linda A. DiMeglio, Larry A. Fox, Henry Rodriguez, Dorothy I. Shulman, Kevin B. Kaiserman, David R. Liljenquist, John Shin, Scott W. Lee, Bruce A. Buckingham
Publikováno v:
Pediatric Diabetes. 23:324-329
Highly variable insulin sensitivity, susceptibility to hypoglycemia and inability to effectively communicate hypoglycemic symptoms pose significant challenges for young children with type 1 diabetes (T1D). Herein, outcomes during clinical MiniMed™
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b614db1632625505ff7c58ddbd235f65
https://doi.org/10.1111/pedi.13312
https://doi.org/10.1111/pedi.13312
Autor:
Steven J, Russell, Roy W, Beck, Edward R, Damiano, Firas H, El-Khatib, Katrina J, Ruedy, Courtney A, Balliro, Zoey, Li, Peter, Calhoun, R Paul, Wadwa, Bruce, Buckingham, Keren, Zhou, Mark, Daniels, Philip, Raskin, Perrin C, White, Jane, Lynch, Jeremy, Pettus, Irl B, Hirsch, Robin, Goland, John B, Buse, Davida, Kruger, Nelly, Mauras, Andrew, Muir, Janet B, McGill, Fran, Cogen, Jill, Weissberg-Benchell, Jordan S, Sherwood, Luz E, Castellanos, Mallory A, Hillard, Marwa, Tuffaha, Melissa S, Putman, Mollie Y, Sands, Gregory, Forlenza, Robert, Slover, Laurel H, Messer, Erin, Cobry, Viral N, Shah, Sarit, Polsky, Rayhan, Lal, Laya, Ekhlaspour, Michael S, Hughes, Marina, Basina, Betul, Hatipoglu, Leann, Olansky, Amrit, Bhangoo, Nikta, Forghani, Himala, Kashmiri, Francoise, Sutton, Abha, Choudhary, Jimmy, Penn, Rabab, Jafri, Maria, Rayas, Elia, Escaname, Catherine, Kerr, Ruby, Favela-Prezas, Schafer, Boeder, Subbulaxmi, Trikudanathan, Kristen M, Williams, Natasha, Leibel, M Sue, Kirkman, Kate, Bergamo, Klara R, Klein, Jean M, Dostou, Sriram, Machineni, Laura A, Young, Jamie C, Diner, Arti, Bhan, J Kimberly, Jones, Matthew, Benson, Keisha, Bird, Kimberly, Englert, Joe, Permuy, Kristina, Cossen, Eric, Felner, Maamoun, Salam, Julie M, Silverstein, Samantha, Adamson, Andrea, Cedeno, Seema, Meighan, Carol, Wysham
Publikováno v:
The New England journal of medicine. 387(13)
Currently available semiautomated insulin-delivery systems require individualized insulin regimens for the initialization of therapy and meal doses based on carbohydrate counting for routine operation. In contrast, the bionic pancreas is initialized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8176300ea04bd513d06ebac48976b050
https://pubmed.ncbi.nlm.nih.gov/36170505
https://pubmed.ncbi.nlm.nih.gov/36170505
Publikováno v:
J Diabetes Sci Technol
Closed-loop insulin delivery systems are fast becoming the standard of care in the management of type 1 diabetes and have led to significant improvements in diabetes management. Nevertheless, there is still room for improvement for the closed-loop sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11408f969236efe3d0eedd411b418357
https://doi.org/10.1177/19322968211032701
https://doi.org/10.1177/19322968211032701
Autor:
Erin C, Cobry, Lauren G, Kanapka, Eda, Cengiz, Lori, Carria, Laya, Ekhlaspour, Bruce A, Buckingham, Korey K, Hood, Liana J, Hsu, Laurel H, Messer, Melissa J, Schoelwer, Emma, Emory, Katrina J, Ruedy, Roy W, Beck, Raj Paul, Wadwa, Linda, Gonder-Frederick, Deanna, Gabrielson
Publikováno v:
Diabetes Technol Ther
Introduction: Hybrid closed-loop systems increase time-in-range (TIR) and reduce glycemic variability. Person-reported outcomes (PROs) are essential to assess the utility of new devices and their impact on quality of life. This article focuses on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::232cf93586d5eb9639a7ef6dff0ae05f
https://doi.org/10.1089/dia.2020.0532
https://doi.org/10.1089/dia.2020.0532